Possible mechanisms underlying an increased risk of postoperative infection in association with white-cell–containing allogeneic blood transfusion
Hypothesis . | Reduction in the risk of postoperative infection following the implementation of prestorage WBC reduction? . | Increased risk of postoperative infection as the length of storage of the transfused cellular blood components increases? . | |
---|---|---|---|
Before the implementation of prestorage WBC reduction? . | After the implementation of prestorage WBC reduction? . | ||
1. Transfusion of older RBCs results in tissue hypoxia, which predisposes to postoperative infection. | No | Yes | Yes |
2. Biologic response modifiers, released from deteriorating WBCs and accumulating in the supernatant fluid of cellular blood components, mediate adverse TRIM effects. | Yes | Yes | No |
3. Immunologically active, intact allogeneic WBCs mediate adverse TRIM effects. | Yes | No | No |
Hypothesis . | Reduction in the risk of postoperative infection following the implementation of prestorage WBC reduction? . | Increased risk of postoperative infection as the length of storage of the transfused cellular blood components increases? . | |
---|---|---|---|
Before the implementation of prestorage WBC reduction? . | After the implementation of prestorage WBC reduction? . | ||
1. Transfusion of older RBCs results in tissue hypoxia, which predisposes to postoperative infection. | No | Yes | Yes |
2. Biologic response modifiers, released from deteriorating WBCs and accumulating in the supernatant fluid of cellular blood components, mediate adverse TRIM effects. | Yes | Yes | No |
3. Immunologically active, intact allogeneic WBCs mediate adverse TRIM effects. | Yes | No | No |
Expected results from observational comparisons of patients transfused before or after the implementation of universal WBC reduction.